Works matching Alternative treatment for multiple sclerosis

Results: 58

Complementary and alternative medicine for the treatment of multiple sclerosis.

Published in:

Expert Review of Clinical Immunology, 2010, v. 6, n. 3, p. 381, doi. 10.1586/eci.10.12

By:

Yadav, Vijayshree;
Shinto, Lynne;
Bourdette, Dennis

Publication type:

Article

Use of Alternative Treatments by People with Multiple Sclerosis.

Published in:

Neurorehabilitation & Neural Repair, 1999, v. 13, n. 4, p. 243, doi. 10.1177/154596839901300406

By:

Berkman, Cathy S.;
Pignotti, Monica G.;
Cavallo, Pamela F.;
Holland, Nancy J.

Publication type:

Article

Systematic literature review and network meta-analysis of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis.

Published in:

2018

By:

Siddiqui, Mohd Kashif;
Khurana, Inderpreet Singh;
Budhia, Sangeeta;
Hettle, Robert;
Harty, Gerard;
Wong, Schiffon L.

Publication type:

journal article

Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis (Review).

Published in:

Medicine International (2754-3242), 2023, v. 3, n. 5, p. 1, doi. 10.3892/mi.2023.102

By:

FATHALLAH, SARA;
ABDELLATIF, AHMED;
SAADELDIN, MONA KAMAL

Publication type:

Article

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis.

Published in:

European Journal of Neurology, 2009, v. 16, n. 11, p. 1202, doi. 10.1111/j.1468-1331.2009.02708.x

By:

Prosperini, L.;
Gallo, V.;
Petsas, N.;
Borriello, G.;
Pozzilli, C.

Publication type:

Article

Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.

Published in:

European Neurology, 2016, v. 75, n. 5/6, p. 236, doi. 10.1159/000445943

By:

Haupts, Michael;
Vila, Carlos;
Jonas, anna;
Witte, Kerstin;
Álvarez-Ossorio, Lourdes

Publication type:

Article

Estimating the comparative efficacy of cladribine tablets versus alternative disease modifying treatments in active relapsing-remitting multiple sclerosis: adjusting for patient characteristics using meta-regression and matching-adjusted indirect treatment comparison approaches.

Published in:

2019

By:

Berardi, Andrea;
Siddiqui, Mohd Kashif;
Treharne, Catrin;
Harty, Gerard;
Wong, Schiffon L.

Publication type:

journal article

Natalizumab and Beyond.

Published in:

European Neurology, 2010, v. 64, n. 4, p. 236, doi. 10.1159/000317583

By:

Yildiz, Murat;
Tettenborn, Barbara;
Putzki, Norman

Publication type:

Article

Hypnotherapy as a Nonpharmacological Treatment for the Psychological Symptoms of Multiple Sclerosis.

Published in:

Alternative Therapies in Health & Medicine, 2023, v. 29, n. 4, p. 266

By:

Maresca, Giuseppa;
Nocito, Vanessa;
Lo Buono, Viviana;
Latella, Desiree;
Di Cara, Marcella;
Formica, Caterina;
Carnazza, Lara;
Sessa, Edoardo;
Bramanti, Placido;
Corallo, Francesco

Publication type:

Article

Fate of multiple sclerosis patients positive for neutralising antibodies towards interferon beta shifted to alternative treatments.

Published in:

Neurological Sciences, 2005, v. 26, p. s213, doi. 10.1007/s10072-005-0517-3

By:

Malucchi, S.;
Capobianco, M.;
Gilli, F.;
Marnetto, F.;
Caldano, M.;
Sala, A.;
Bertolotto, A.

Publication type:

Article

Netradicinės ir alternatyvios medicinos terapijos, taikomos išsėtinei sklerozei gydyti.

Published in:

Neurologijos Seminarai, 2012, v. 16, n. 1, p. 18

By:

Šešeikaitė, M.;
Kizlaitienė, R.;
Budrys, V.

Publication type:

Article

Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14478, doi. 10.3390/ijms232214478

By:

Dziedzic, Angela;
Saluk, Joanna

Publication type:

Article

Intellectual enrichment is linked to cerebral efficiency in multiple sclerosis: functional magnetic resonance imaging evidence for cognitive reserve.

Published in:

2010

By:

Sumowski, J. F.;
Wylie, G. R.;
Deluca, J.

Publication type:

Opinion

Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis.

Published in:

2010

By:

Mangano, K.;
Nicoletti, A.;
Patti, F.

Publication type:

Opinion

Combination therapy in multiple sclerosis.

Published in:

2010

By:

Conway, D.;
Cohen, J. A.

Publication type:

Opinion

IMPROVING FUNCTIONAL STATUS IN MULTIPLE SCLEROSIS PATIENTS BY PHYSICAL KINETIC, BALNEARY AND POSITIVE PSYCHOLOGY.

Published in:

2017

By:

A., Bichis;
L., Cioc;
H., Lazarescu;
D., Cinteza

Publication type:

Abstract

Session 4310 (Symposium).

Published in:: 2021
Publication type:: Abstract

The Use of Complementary and Alternative Medicine by Multiple Sclerosis Patients in Turkey.

Published in:

Gulhane Medical Journal, 2014, v. 56, n. 2, p. 71, doi. 10.5455/gulhane.39346

By:

Basak, Tulay;
Unver, Vesile;
Demirkaya, Seref

Publication type:

Article

IN THE SAME VEIN.

Published in:

Nursing Standard, 2011, v. 25, n. 42, p. 21, doi. 10.7748/ns.25.42.21.s27

By:

Whyte, Alison

Publication type:

Article

Multiple sclerosis, cognitive dysfunction and the potential benefits of exercise.

Published in:

2011

By:

Feinstein, Anthony

Publication type:

Editorial

Dimethyl Fumarat - a New Player in Oral Treatment Options for Relapsing Forms of Multiple Sclerosis.

Published in:

Maedica - a Journal of Clinical Medicine, 2014, v. 9, n. 4, p. 408

By:

ANTOCHI, Florina

Publication type:

Article

"Liberation" death.

Published in:

Canadian Medical Association Journal (CMAJ), 2011, v. 183, n. 11, p. E723, doi. 10.1503/cmaj.109-3936

By:

Collier, Roger

Publication type:

Article

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.

Published in:

Multiple Sclerosis (13524585), 2009, v. 15, n. 9, p. 1037, doi. 10.1177/1352458509106543

By:

Weber-Schoendorfer, C.;
Schaefer, C.

Publication type:

Article

The IMCO Scheme as a Tool in Developing Team-Based Treatment for People with Multiple Sclerosis.

Published in:

Journal of Alternative & Complementary Medicine, 2008, v. 14, n. 1, p. 69, doi. 10.1089/acm.2007.0593

By:

Launsø, Laila;
Skovgaard, Lasse

Publication type:

Article

The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy.

Published in:

Life (2075-1729), 2021, v. 11, n. 2, p. 101, doi. 10.3390/life11020101

By:

Yordanova, Ivet A.;
Ebner, Friederike;
Schulz, Axel Ronald;
Steinfelder, Svenja;
Rosche, Berit;
Bolze, Anna;
Paul, Friedemann;
Mei, Henrik E.;
Hartmann, Susanne;
Cutillas, Cristina

Publication type:

Article

Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain.

Published in:

Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.727586

By:

Landete, Lamberto;
Pérez-Miralles, Francisco;
García, Sara;
Belenguer, Antonio;
Gascón, Francisco;
Domínguez, Jose Andres;
Carcelén-Gadea, María;
Quintanilla, Carlos;
Navarro, Laura;
Gabaldón, Laura;
Casanova, Bonaventura

Publication type:

Article

Distribution of transplanted human mesenchymal stem cells from Wharton's Jelly in the central nervous systems of the EAE rats.

Published in:

Biopolymers & Cell, 2015, v. 31, n. 5, p. 371, doi. 10.7124/bc.0008F9

By:

Kovalchuk, M. V.;
Deryabina, O. G.;
Pichkur, L. D.;
Verbovskaya, S. A.;
Shuvalova, N. S.;
Pichkur, O. L.;
Kordium, V. A.

Publication type:

Article

Comparison of healthcare utilization among managed Medicaid individuals diagnosed with multiple sclerosis treated with emergent versus established disease modifying therapy.

Published in:

2019

By:

Parente, Alexis;
Sutton, Bryce;
Petrilla, Allison;
Teigland, Christie

Publication type:

Abstract

Comparison of healthcare utilization among managed Medicaid individuals diagnosed with multiple sclerosis treated with emergent versus established disease modifying therapy.

Published in:

2019

By:

Parente, Alexis;
Sutton, Bryce;
Petrilla, Allison;
Teigland, Christie

Publication type:

Abstract

Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).

Published in:

2015

By:

Klotz, Luisa;
Grützke, Berit;
Eveslage, Maria;
Deppe, Michael;
Gross, Catharina C;
Kirstein, Lucienne;
Posevitz-Fejfar, Anita;
Schneider-Hohendorf, Tilman;
Schwab, Nicholas;
Meuth, Sven G;
Wiendl, Heinz

Publication type:

journal article

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.

Published in:

Multiple Sclerosis Journal, 2020, v. 26, n. 12, p. 1532, doi. 10.1177/1352458519866600

By:

Granqvist, Mathias;
Burman, Joachim;
Gunnarsson, Martin;
Lycke, Jan;
Nilsson, Petra;
Olsson, Tomas;
Sundström, Peter;
Svenningsson, Anders;
Vrethem, Magnus;
Frisell, Thomas;
Piehl, Fredrik

Publication type:

Article

Meta-Analysis of Clinical Trials with Copolymer 1 in Multiple Sclerosis.

Published in:

European Neurology, 2000, v. 43, n. 4, p. 189, doi. 10.1159/000008174

By:

La Mantia;
Milanese;
D’Amico

Publication type:

Article

Polyunsaturated Fatty Acid Supplementation Stimulates Differentiation of Oligodendroglia Cells.

Published in:

Developmental Neuroscience, 2006, v. 28, n. 3, p. 196, doi. 10.1159/000091917

By:

van Meeteren, M. E.;
Baron, W.;
Beermann, C.;
Dijkstra, C. D.;
van Tol, E. A. F.

Publication type:

Article

Haematopoietic progenitor cells from adult bone marrow differentiate into cells that express oligodendroglial antigens in the neonatal mouse brain.

Published in:

European Journal of Neuroscience, 2002, v. 15, n. 3, p. 575, doi. 10.1046/j.1460-9568.2002.01895.x

By:

Bonilla, Sonia;
Alarcón, Pedro;
Villaverde, Ramón;
Aparicio, Pedro;
Silva, Augusto;
Martínez, Salvador

Publication type:

Article

S1P РЕЦЕПТОРНИ МОДУЛАТОРИ ЗА ЛЕЧЕНИЕ НА ПРИСТЪПНО-РЕМИТЕНТНА ФОРМА НА МУЛТИПЛЕНА СКЛЕРОЗА – ИКОНОМИЧЕСКИ МРЕЖОВ МЕТААНАЛИЗ.

Published in:

Neurology & Psychiatry, 2022, v. 53, n. 1, p. 3

By:

Веков, Т.;
Велева, Н.;
Драганова, М.;
Колев, Ж.

Publication type:

Article

Association of miRNA and mRNA Levels of the Clinical Onset of Multiple Sclerosis Patients.

Published in:

Biology (2079-7737), 2021, v. 10, n. 6, p. 554, doi. 10.3390/biology10060554

By:

Piotrzkowska, Danuta;
Miller, Elzbieta;
Kucharska, Ewa;
Niwald, Marta;
Majsterek, Ireneusz

Publication type:

Article

Immunoadsorption or plasma exchange in steroid‐refractory multiple sclerosis and neuromyelitis optica.

Published in:

Journal of Clinical Apheresis, 2019, v. 34, n. 4, p. 381, doi. 10.1002/jca.21686

By:

Lipphardt, Mark;
Mühlhausen, Johannes;
Kitze, Bernd;
Heigl, Franz;
Mauch, Erich;
Helms, Hans‐Joachim;
Müller, Gerhard A.;
Koziolek, Michael J.

Publication type:

Article

Spasticity in multiple sclerosis and role of glatiramer acetate treatment.

Published in:

Brain & Behavior, 2015, v. 5, n. 9, p. n/a, doi. 10.1002/brb3.367

By:

Meca‐Lallana, Jose Eustasio;
Hernández‐Clares, Rocío;
Carreón‐Guarnizo, Ester

Publication type:

Article

A Real-World Experience of Azathioprine Versus First-Line Disease-Modifying Therapy in Relapsing-Remitting Multiple Sclerosis—A Prospective Cohort Study.

Published in:

Brain Sciences (2076-3425), 2023, v. 13, n. 9, p. 1249, doi. 10.3390/brainsci13091249

By:

Agrawal, Arpit;
Srivastava, M. V. Padma;
Bhatia, Rohit;
Goyal, Vinay;
Singh, Mamta Bhushan;
Vishnu, Venugopalan Y.;
Prabhakar, Anuj

Publication type:

Article

FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.

Published in:

Human Molecular Genetics, 2014, v. 23, n. 9, p. 2251, doi. 10.1093/hmg/ddt615

By:

Di Pardo, Alba;
Amico, Enrico;
Favellato, Mariagrazia;
Castrataro, Roberta;
Fucile, Sergio;
Squitieri, Ferdinando;
Maglione, Vittorio

Publication type:

Article

Integrative Care and Bridge Building Among Health Care Providers in Norway and Denmark.

Published in:

Journal of Alternative & Complementary Medicine, 2006, v. 12, n. 2, p. 141, doi. 10.1089/acm.2006.12.141

By:

Gamst, Are;
Haahr, Niels;
Kristoffersen, Agnete Egilsdatter;
Launsø, Laila

Publication type:

Article

Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.

Published in:

2012

By:

Skovgaard, L.;
Nicolajsen, P. H.;
Pedersen, E.;
Kant, M.;
Fredrikson, S.;
Verhoef, M.;
Meyrowitsch, D. W.

Publication type:

Journal Article

Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.

Published in:

Autoimmune Diseases (2090-0422), 2012, p. 1, doi. 10.1155/2012/841085

By:

Skovgaard, L.;
Nicolajsen, P. H.;
Pedersen, E.;
Kant, M.;
Fredrikson, S.;
Verhoef, M.;
Meyrowitsch, D. W.

Publication type:

Article

Applications of whole body vibration therapy in the clinical setting: a brief review.

Published in:

2012

By:

Kessler, Nathan;
Kim, Sylvia;
McGeehan, Michael;
Hong, Junggi

Publication type:

Journal Article

Applications of whole body vibration therapy in the clinical setting: a brief review.

Published in:

International Journal of Therapy & Rehabilitation, 2012, v. 19, n. 7, p. 405, doi. 10.12968/ijtr.2012.19.7.405

By:

Kessler, Nathan;
Kim, Sylvia;
McGeehan, Michael;
Hong, Junggi

Publication type:

Article

Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months.

Published in:: Current Medical Literature: Multiple Sclerosis, 2010, v. 1, n. 4, p. 95
Publication type:: Article

Feasibility of a smartphone app to enhance physical activity in progressive MS: a pilot randomized controlled pilot trial over three months.

Published in:

PeerJ, 2020, p. 1, doi. 10.7717/peerj.9303

By:

Nasseri, Navina N.;
Ghezelbash, Eghbal;
Yuyang Zhai;
Patra, Stefan;
Riemann-Lorenz, Karin;
Heesen, Christoph;
Rahn, Anne C.;
Stellmann, Jan-Patrick

Publication type:

Article

Fingolimod in pediatric-onset multiple sclerosis.

Published in:

2021

By:

Zaffaroni, Mauro

Publication type:

Editorial

The Synergistic Anti-Apoptosis Effects of Amniotic Epithelial Stem Cell Conditioned Medium and Ponesimod on the Oligodendrocyte Cells.

Published in:

Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.691099

By:

Safaeinejad, Fahimeh;
Asadi, Sareh;
Ghafghazi, Shiva;
Niknejad, Hassan

Publication type:

Article

Propofol hemisuccinate suppression of experimental autoimmune encephalomyelitis.

Published in:

Autoimmunity, 2007, v. 40, n. 3, p. 180, doi. 10.1080/08916930701204467

By:

Vansant, G.;
Trauger, R. J.;
Cameron, A.;
Vendemelio, M.;
Kreitschitz, S.;
Carlo, A. T.;
Banaszczyk, M. G.;
Carlo, D. J.;
Hendler, S.;
Ill, C. R.

Publication type:

Article